“…It is striking to note that, like the rodent model, optimized and standardized behavioral assessments are needed to increase the accuracy and reliability of the zebrafish model (Vaz et al, 2018), in parallel with its advancing application in PD studies. Nunes et al, 2017;Wang et al, 2018;Bastías-Candia et al, 2019;Feng et al, 2019;Vaccari et al, 2019;Joseph et al, 2020 Rotenone -Inhibition of the mitochondrial complex I activity -Increased ROS production -Reduced ATP production α-synuclein aggregation -Reduced dopamine level -Reduced mitochondrial calcium level -Increased activation of microglia and pro-inflammatory proteins -Motor impairments (reduced swimming speed, reduced distance traveled) -Anxiety -Depression -Olfactory dysfunction Gao et al, 2013;Wang et al, 2017;Lv et al, 2019;Hijaz and Volpicelli-Daley, 2020;Ramli et al, 2020;Ünal et al, 2020;Yurtsever et al, 2020 Anichtchik et al, 2008;Sallinen et al, 2010;Xi et al, 2010;Priyadarshini et al, 2013 Sheng et al, 2010;Prabhudesai et al, 2016;Sheng et al, 2018;Seegobin et al, 2020 neurotoxin inductions and PD-associated gene mutations on the zebrafish model of PD.…”